143 related articles for article (PubMed ID: 15640947)
1. Proliferative activity in pancreatic intraepithelial neoplasias of chronic pancreatitis resection specimens: detection of a high-risk lesion.
Hermanová M; Nenutil R; Kren L; Feit J; Pavlovský Z; Díte P
Neoplasma; 2004; 51(5):400-4. PubMed ID: 15640947
[TBL] [Abstract][Full Text] [Related]
2. Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression.
Klein WM; Hruban RH; Klein-Szanto AJ; Wilentz RE
Mod Pathol; 2002 Apr; 15(4):441-7. PubMed ID: 11950919
[TBL] [Abstract][Full Text] [Related]
3. p16(INK4a) alterations in chronic pancreatitis-indicator for high-risk lesions for pancreatic cancer.
Gerdes B; Ramaswamy A; Kersting M; Ernst M; Lang S; Schuermann M; Wild A; Bartsch DK
Surgery; 2001 Apr; 129(4):490-7. PubMed ID: 11283541
[TBL] [Abstract][Full Text] [Related]
4. p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis.
Rosty C; Geradts J; Sato N; Wilentz RE; Roberts H; Sohn T; Cameron JL; Yeo CJ; Hruban RH; Goggins M
Am J Surg Pathol; 2003 Dec; 27(12):1495-501. PubMed ID: 14657708
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors.
Takaori K; Kobashi Y; Matsusue S; Matsui K; Yamamoto T
J Hepatobiliary Pancreat Surg; 2003; 10(2):125-36. PubMed ID: 14505145
[TBL] [Abstract][Full Text] [Related]
6. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH
Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454
[TBL] [Abstract][Full Text] [Related]
7. Pathology analysis reveals that dysplastic pancreatic ductal lesions are frequent in patients with hereditary pancreatitis.
Rebours V; Lévy P; Mosnier JF; Scoazec JY; Soubeyrand MS; Fléjou JF; Turlin B; Hammel P; Ruszniewski P; Bedossa P; Couvelard A
Clin Gastroenterol Hepatol; 2010 Feb; 8(2):206-12. PubMed ID: 19765677
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.
Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH
Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
[TBL] [Abstract][Full Text] [Related]
10. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.
Swartz MJ; Batra SK; Varshney GC; Hollingsworth MA; Yeo CJ; Cameron JL; Wilentz RE; Hruban RH; Argani P
Am J Clin Pathol; 2002 May; 117(5):791-6. PubMed ID: 12090430
[TBL] [Abstract][Full Text] [Related]
11. [Pancreatic intraepithelial neoplasia in chronic pancreatitis].
Tannapfel A; Witzigmann H; Wittekind C
Zentralbl Chir; 2001 Nov; 126(11):879-83. PubMed ID: 11753797
[TBL] [Abstract][Full Text] [Related]
12. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia.
van Heek NT; Meeker AK; Kern SE; Yeo CJ; Lillemoe KD; Cameron JL; Offerhaus GJ; Hicks JL; Wilentz RE; Goggins MG; De Marzo AM; Hruban RH; Maitra A
Am J Pathol; 2002 Nov; 161(5):1541-7. PubMed ID: 12414502
[TBL] [Abstract][Full Text] [Related]
13. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma.
Gold DV; Karanjawala Z; Modrak DE; Goldenberg DM; Hruban RH
Clin Cancer Res; 2007 Dec; 13(24):7380-7. PubMed ID: 18094420
[TBL] [Abstract][Full Text] [Related]
14. Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia.
Abe K; Suda K; Arakawa A; Yamasaki S; Sonoue H; Mitani K; Nobukawa B
Pancreas; 2007 Jan; 34(1):85-91. PubMed ID: 17198188
[TBL] [Abstract][Full Text] [Related]
15. Multicentric pancreatic intraepithelial neoplasias (PanINs) presenting with the clinical features of chronic pancreatitis.
Aimoto T; Uchida E; Nakamura Y; Matsushita A; Katsuno A; Chou K; Kawamoto M; Naito Z; Tajiri T
J Hepatobiliary Pancreat Surg; 2008; 15(5):549-53. PubMed ID: 18836812
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components.
Sanada Y; Yoshida K; Ohara M; Oeda M; Konishi K; Tsutani Y
Pancreas; 2006 Mar; 32(2):164-70. PubMed ID: 16552336
[TBL] [Abstract][Full Text] [Related]
17. [Precursors to pancreatic cancer].
Søreide K; Immervoll H; Molven A
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
[TBL] [Abstract][Full Text] [Related]
18. Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment.
Esposito I; Seiler C; Bergmann F; Kleeff J; Friess H; Schirmacher P
Pancreas; 2007 Oct; 35(3):212-7. PubMed ID: 17895840
[TBL] [Abstract][Full Text] [Related]
19. 5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions.
Hennig R; Grippo P; Ding XZ; Rao SM; Buchler MW; Friess H; Talamonti MS; Bell RH; Adrian TE
Cancer Res; 2005 Jul; 65(14):6011-6. PubMed ID: 16024599
[TBL] [Abstract][Full Text] [Related]
20. Current topics on precursors to pancreatic cancer.
Takaori K; Hruban RH; Maitra A; Tanigawa N
Adv Med Sci; 2006; 51():23-30. PubMed ID: 17357272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]